ArticleFrontiers in immunology2025

Impact of inotuzumab ozogamicin as bridging therapy and tumor burden in CAR-T therapy for B-acute lymphoblastic leukemia.

Patricia Alcalde-Mellado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.